Genotypic and epidemiologic trends of norovirus outbreaks in the united states, 2009 to 2013

Journal of Clinical Microbiology

Volumn 52, Issue 1, 2014, Pages 147-155

  Vega, Everardo ^a   Barclay, Leslie ^a   Gregoricus, Nicole ^a   Shirley, S Hannah ^a,b   Lee, David ^a,b   Vinjé, Jan ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CORRELATION ANALYSIS; DISEASE SURVEILLANCE; EPIDEMIC; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC EPIDEMIOLOGY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HIGH RISK PATIENT; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; NOROVIRUS INFECTION; PHYLOGEOGRAPHY; PRIORITY JOURNAL; UNITED STATES; VIRUS DETECTION; VIRUS STRAIN; VIRUS TRANSMISSION;

CALICIVIRIDAE INFECTIONS; DISEASE OUTBREAKS; EPIDEMIOLOGICAL MONITORING; FOODBORNE DISEASES; GASTROENTERITIS; GENOTYPE; HUMANS; MOLECULAR EPIDEMIOLOGY; NOROVIRUS; PHYLOGEOGRAPHY; RNA, VIRAL; UNITED STATES;

EID: 84891541960     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02680-13     Document Type: Article

References (44)

1. Glass RI, Parashar UD, Estes MK. 2009. Norovirus gastroenteritis. N. Engl. J. Med. 361:1776-1785. http://dx.doi.org/10.1056/NEJMra0804575.
2. Payne DC, Vinjé J, Szilagyi PG, Edwards KM, Staat MA, Weinberg GA, Hall CB, Chappell J, Bernstein DI, Curns AT, Wikswo M, Shirley SH, Hall AJ, Lopman B, Parashar UD. 2013. Norovirus and medically attended gastroenteritis in U.S. children. N. Engl. J. Med. 368:1121-1130. http://dx.doi.org/10.1056/ NEJMsa1206589.
3. Lopman BA, Hall AJ, Curns AT, Parashar UD. 2011. Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clin. Infect. Dis. 52:466-474. http://dx.doi.org/10.1093/ cid/ciq163.
4. Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. 2012. The roles of Clostridium difficile and norovirus among gastroenteritisassociated deaths in the United States, 1999-2007. Clin. Infect. Dis. 55: 216-223. http://dx.doi.org/10.1093/cid/cis386.
5. Hall AJ, Lopman BA, Payne DC, Patel MM, Gastañaduy PA, Vinjé J, Parashar UD. 2013. Norovirus disease in the United States. Emerg. Infect. Dis. 19:1198-1205. http://dx.doi.org/10.3201/eid1908.130465.
6. Green K. 2013. Caliciviridae: The noroviruses, p 583-609. In Knipe DM, Howley PM (ed), Fields virology, 6th ed, vol 1. Lippincott Williams & Wilkins, Philadelphia, PA.
7. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. 2006. Norovirus classification and proposed strain nomenclature. Virology 346:312-323. http://dx.doi.org/10.1016/j.virol.2005.11.015.
8. Kroneman A, Vega E, Vennema H, Vinjé J, White PA, Hansman G, Green K, Martella V, Katayama K, Koopmans M. 2013. Proposal for a unified norovirus nomenclature and genotyping. Arch. Virol. 158:2059-2068. http://dx.doi.org/10. 1007/s00705-013-1708-5.
9. Martella V, Decaro N, Lorusso E, Radogna A, Moschidou P, Amorisco F, Lucente MS, Desario C, Mari V, Elia G, Banyai K, Carmichael LE, Buonavoglia C. 2009. Genetic heterogeneityandrecombination in canine noroviruses. J. Virol. 83:11391-11396. http://dx.doi.org/10.1128/JVI.01385-09.
10. Siebenga JJ, Vennema H, Zheng DP, Vinjé J, Lee BE, Pang XL, Ho EC, Lim W, Choudekar A, Broor S, Halperin T, Rasool NB, Hewitt J, Greening GE, Jin M, Duan ZJ, Lucero Y, O'Ryan M, Hoehne M, Schreier E, Ratcliff RM, White PA, Iritani N, Reuter G, Koopmans M. 2009. Norovirus illness is a global problem: Emergence and spread of norovirus GII.4 variants, 2001-2007. J. Infect. Dis. 200:802-812. http://dx.doi.org/10.1086/605127.
11. Vega E, Barclay L, Gregoricus N, Williams K, Lee D, Vinjé J. 2011. Novel surveillance network for norovirus gastroenteritis outbreaks, United States. Emerg. Infect. Dis. 17:1389-1395. http://dx.doi.org/10 .3201/eid1708.101837.
12. Zheng DP, Widdowson MA, Glass RI, Vinjé J. 2010. Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006. J. Clin. Microbiol. 48:168-177. http://dx.doi.org/10.1128/JCM. 01622-09.
13. Debbink K, Lindesmith LC, Donaldson EF, Baric RS. 2012. Norovirus immunity and the great escape. PLoS Pathog. 8:e1002921. http://dx.doi.org/10. 1371/journal.ppat.1002921.
14. Leshem E, Wikswo M, Barclay L, Brandt E, Storm W, Salehi E, Desalvo T, Davis T, Saupe A, Dobbins G, Booth HA, Biggs C, Garman K, Woron AM, Parashar UD, Vinjé J, Hall AJ. 2013. Effects and clinical significance of GII.4 Sydney norovirus, United States, 2012-2013. Emerg. Infect. Dis. 19:1231-1238. http://dx.doi.org/10.3201/eid1908.130458.
15. Centers for Disease Control and Prevention. 2007. Norovirus activity-United States, 2006-2007.MMWRMorb. Mortal. Wkly. Rep. 56:842-846.
16. Yen C, Wikswo ME, Lopman BA, Vinjé J, Parashar UD, Hall AJ. 2011. Impact of an emergent norovirus variant in 2009 on norovirus outbreak activity in the United States. Clin. Infect. Dis. 53:568-571. http://dx.doi.org/10.1093/ cid/cir478.
17. Vongpunsawad S, Prasad BV, Estes MK. 2013. Norwalk virus minor capsid protein VP2 associates within the VP1 shell domain. J. Virol. 87: 4818-4825. http://dx.doi.org/10.1128/JVI.03508-12.
18. Xerry J, Gallimore CI, Iturriza-Gómara M, Allen DJ, Gray JJ. 2008. Transmission events within outbreaks of gastroenteritis determined through analysis of nucleotide sequences of the P2 domain of genogroup II noroviruses. J. Clin. Microbiol. 46:947-953. http://dx.doi.org/10.1128/JCM.02240-07.
19. Sukhrie FH, Beersma MF, Wong A, van der Veer B, Vennema H, Bogerman J, Koopmans M. 2011. Using molecular epidemiology to trace transmission of nosocomial norovirus infection. J. Clin. Microbiol. 49: 602-606. http://dx.doi.org/10.1128/JCM.01443-10.
20. Sukhrie FH, Teunis P, Vennema H, Bogerman J, van Marm S, Beersma MF, Koopmans M. 2013. P2 domain profiles and shedding dynamics in prospectively monitored norovirus outbreaks. J. Clin. Virol. 56:286-292. http://dx.doi.org/10. 1016/j.jcv.2012.12.006.
21. Vega E, Vinjé J. 2011. Novel GII.12 norovirus strain, United States, 2009-2010. Emerg. Infect. Dis. 17:1516-1518. http://dx.doi.org/10.3201/ eid1708.110025.
22. Leshem E, Barclay L, Wikswo M, Vega E, Gregoricus N, Parashar UD, Vinjé J, Hall AJ. 2013. Genotype GI.6 norovirus, United States, 2010-2012. Emerg. Infect. Dis. 19:1317-1320. http://dx.doi.org/10.3201/eid1908. 130445.
23. Bennett S, MacLean A, Miller RS, Aitken C, Gunson RN. 2013. Increased norovirus activity in Scotland in 2012 is associated with the emergence of a new norovirus GII.4 variant. Euro Surveill. 18:pii-20349. http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId-20349.
24. Fonager J, Hindbæk LS, Fischer TK. 2013. Rapid emergence and antigenic diversification of the norovirus 2012 Sydney variant in Denmark, October to December, 2012. Euro Surveill. 18:pii-20413. http://www .eurosurveillance.org/ViewArticle.aspx?ArticleId-20413.
25. van Beek J, Ambert-Balay K, Botteldoorn N, Eden JS, Fonager J, Hewitt J, Iritani N, Kroneman A, Vennema H, Vinjé J, White PA, Koopmans M, NoroNet. 2013. Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012. Euro Surveill. 18:pii-20345. http://www .eurosurveillance.org/ViewArticle.aspx?ArticleId-20345.
26. Centers for Disease Control and Prevention. 2013. Emergence of new norovirus strain GII.4 Sydney-United States, 2012.MMWRMorb. Mortal. Wkly. Rep. 62:55.
27. Spackova M, Altmann D, Eckmanns T, Koch J, Krause G. 2010. High level of gastrointestinal nosocomial infections in the German surveillance system, 2002-2008. Infect. Control Hosp. Epidemiol. 31:1273-1278. http://dx.doi.org/10. 1086/657133.
28. Reber AJ, Chirkova T, Kim JH, Cao W, Biber R, Shay DK, Sambhara S. 2012. Immunosenescence and challenges of vaccination against influenza in the aging population. Aging Dis. 3:68-90.
29. Paulke-Korinek M, Kundi M, Laaber B, Brodtraeger N, Seidl-Friedrich C, Wiedermann U, Kollaritsch H. 2013. Factors associated with seroimmunity against tick borne encephalitis virus 10 years after booster vaccination. Vaccine 31:1293-1297. http://dx.doi.org/10.1016/j.vaccine.2012.12.075.
30. Lindesmith LC, Beltramello M, Donaldson EF, Corti D, Swanstrom J, Debbink K, Lanzavecchia A, Baric RS. 2012. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog. 8:e1002705. http://dx.doi.org/10.1371/ journal.ppat.1002705.
31. Debbink K, Lindesmith LC, Donaldson EF, Costantini V, Beltramello M, Corti D, Swanstrom J, Lanzavecchia A, Vinjé J, Baric RS. 1 August 2013. Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity. J. Infect. Dis. [Epub ahead of print.] http://dx.doi.org/10. 1093/infdis/jit370.
32. Kroneman A, Verhoef L, Harris J, Vennema H, Duizer E, van Duynhoven Y, Gray J, Iturriza M, Böttiger B, Falkenhorst G, Johnsen C, von Bonsdorff CH, Maunula L, Kuusi M, Pothier P, Gallay A, Schreier E, Höhne M, Koch J, Szücs G, Reuter G, Krisztalovics K, Lynch M, McKeown P, Foley B, Coughlan S, Ruggeri FM, Di Bartolo I, Vainio K, Isakbaeva E, Poljsak-Prijatelj M, Grom AH, Mijovski JZ, Bosch A, Buesa J, Fauquier AS, Hernandéz-Pezzi G, Hedlund KO, Koopmans M. 2008. Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the Foodborne Viruses in Europe network from 1 July 2001 to 30 June 2006. J. Clin. Microbiol. 46:2959-2965. http://dx.doi.org/10.1128/JCM.00499-08.
33. Hall AJ, Wikswo ME, Manikonda K, Roberts VA, Yoder JS, Gould LH. 2013. Acute gastroenteritis surveillance through the National Outbreak Reporting System, United States. Emerg. Infect. Dis. 19:1305-1309. http://dx.doi.org/10. 3201/eid1908.130482.
34. Verhoef L, Vennema H, van Pelt W, Lees D, Boshuizen H, Henshilwood K, Koopmans M, Food-Borne Viruses in Europe Network. 2010. Use of norovirus genotype profiles to differentiate origins of foodborne outbreaks. Emerg. Infect. Dis. 16:617-624. http://dx.doi.org/10 .3201/eid1604.090723.
35. Xerry J, Gallimore CI, Iturriza-Gómara M, Gray JJ. 2010. Genetic characterization of geno groupInoro virus in out breaks of gastroenteritis. J. Clin.Microbiol. 48:2560-2562. http://dx.doi.org/10.1128/JCM.00798-10.
36. Lindesmith LC, Costantini V, Swanstrom J, Debbink K, Donaldson EF, Vinjé J, Baric RS. 2013. Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes. J. Virol. 87:2803-2813. http://dx.doi.org/10.1128/JVI.03106-12.
37. Shanker S, Choi JM, Sankaran B, Atmar RL, Estes MK, Prasad BV. 2011. Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: Implications for epochal evolution. J. Virol. 85:8635-8645. http://dx.doi.org/10.1128/JVI.00848-11.
38. Bull RA, Eden JS, Rawlinson WD, White PA. 2010. Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog. 6:e1000831. http://dx.doi.org/10.1371/journal.ppat.1000831.
39. Iritani N, Kaida A, Abe N, Sekiguchi J, Kubo H, Takakura K, Goto K, Ogura H, Seto Y. 2012. Increase of GII.2 norovirus infections during the 2009-2010 season in Osaka City, Japan. J. Med. Virol. 84:517-525. http://dx.doi.org/10. 1002/jmv.23211.
40. Eden JS, Tanaka MM, Boni MF, Rawlinson WD, White PA. 2013. Recombination within the pandemic norovirus GII.4 lineage. J. Virol. 87:6270-6282. http://dx.doi.org/10.1128/JVI.03464-12.
41. Motomura K, Yokoyama M, Ode H, Nakamura H, Mori H, Kanda T, Oka T, Katayama K, Noda M, Tanaka T, Takeda N, Sato H, Norovirus Surveillance Group of Japan. 2010. Divergent evolution of norovirus GII/4 by genome recombination from May 2006 to February 2009 in Japan. J. Virol. 84:8085-8097. http://dx.doi.org/10.1128/JVI.02125-09.
42. Gallay A, De Valk H, Cournot M, Ladeuil B, Hemery C, Castor C, Bon F, Mégraud F, Le Cann P, Desenclos JC, Outbreak Investigation Team. 2006. A large multi-pathogen waterborne community outbreak linked to faecal contamination of a groundwater system, France, 2000. Clin. Microbiol. Infect. 12:561-570. http://dx.doi.org/10.1111/j.1469-0691.2006 .01441.x.
43. Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, Ferreira J, Estes MK, Graham DY, Opekun AR, Richardson C, Mendelman PM. 2011. Norovirus vaccine against experimental human Norwalk virus illness. N. Engl. J. Med. 365:2178-2187. http://dx.doi.org/10.1056/NEJMoa1101245.
44. Kundu S, Lockwood J, Depledge DP, Chaudhry Y, Aston A, Rao K, Hartley JC, Goodfellow I, Breuer J. 2013. Next-generation whole genome sequencing identifies the direction of norovirus transmission in linked patients. Clin. Infect. Dis. 57:407-414. http://dx.doi.org/10.1093/cid/cit287.